Today’s AI Top Pick: ALC

9/16/2026 · Forecast Pure screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · Forecast PureALCBUY NOW7.8 / 109/16/2026

ALC (Alcon) is the cleanest multi-timeframe bullish setup in the pool with the best risk-adjusted profile. Every available timeframe agrees directionally: 4h forecasts +18.16%/+16.29%/+22.11% short/mid/long, 1d +9.89%/+12.69%/+14.80%, and 1wk +3.20%/+13.41%/+20.21%. No single-bar outliers, no whipsaw between timeframes — this is model-internal consistency at its best, not the kind of extreme unicorn print that usually reverses. Critically, ALC is NOT at the top of its range. Position in the 21-bar range is 1.29% (4h), 6.93% (1d), 34.56% (1wk) with drawdown of ~10% from the 21-bar high on the daily. RSI 38.55 is oversold-leaning but not capitulation. This is the definition of a pullback-in-uptrend setup: you're buying weakness, not chasing strength. Contrast with NMM/TRMD/GGB which sit at 100% of range with bearish forecasts — literally the opposite setup. Fundamentals are healthy: profitMargin 5.92%, ROE 2.94% (low but positive), debtEq only 0.25, salesYoY +8.34%, epsNextY +13.6%, recom 1.78 (Buy), targetUpsidePct +28.9%. Yes, PE 51.96 is stretched, but fwdPe 17.08 is reasonable for medtech. The news tape supports the thesis — Needham reiterated Buy with $98 PT on 9/15 (that's +47% from $66.60), and Zacks tagged it a portfolio hold on 9/4. No landmines. Why today, not wait? The daily is only ~10% off its high with RSI in the mid-30s and every forecast horizon pointing up. Waiting for a deeper pullback risks missing a snap-back rally that Kronos is projecting into +14–22% over the mid/long horizon. Passing on NCLH/VFC/SHAK (also multi-TF bullish) because each has a recent negative headline (Wells Fargo cruise target cut, Baird downgrade of VFC to Neutral with $15 PT, StockStory 'avoid SHAK'), while ALC has an active analyst upgrade fresh on the tape.

Entry zone

$65.80 – $67.20 (scale in; anchor near current $66.60)

Stop loss

$62.40 (below the 21-bar low, ~-6.3% risk)

First target

$73.50 (+10.4%, matches 4h/1d mid forecast cluster)

Longer target

$80.00 – $82.00 (+20–23%, matches 4h/1wk long forecast and half-way to Needham $98 PT)

Risks

PE of 51.96 leaves valuation vulnerable to any earnings miss; profitMargin is only 5.92%
Forecast magnitudes are modest (+15–22% long) compared to PATK/NCLH; you're paying for consistency, not upside slugging
Healthcare/medtech regulatory risk — STAAR Surgical hiring former CEO for commercial team (9/11) is a competitive-pressure signal in ocular surgery
Stock is in a -10% drawdown that could extend to -15% if broader market rolls over given 1wk pos_in_range is only 34%
Instl ownership 53% is on the lighter side vs. large-cap peers — less sticky holder base

Honorable mentions

PATKStrongest short/mid forecast in the fundamentally-clean bucket (+61.8% 4h short, +45.6% 1d mid), RSI 25.29 deeply oversold, pos_in_range 0 on both 4h and 1d, no negative headlines, fwdPe 13.32 and peg 0.89. Loses the top slot only because 1wk forecast is nearly flat (+1.8/-3.9/+8.3) — the weekly doesn't confirm the daily surge, hinting the projected bounce may be countertrend.

NCLHOnly name with all 4 timeframes (1h/4h/1d/1wk) aligned bullish across short/mid/long horizons, RSI 25.13 washed out, pos_in_range 0–17% across all TFs, forecast +28–46% mid horizon. Downgraded from #1 due to debtEq 6.21 (extreme leverage) and cruise-sector negative headlines (Wells Fargo trimmed Carnival target; NCLH fell 3% in sympathy) — the setup is real but the tape is fighting it right now.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	ALC	BUY NOW	7.8	Clean multi-TF bullish across all horizons, RSI 38.5, Needham Buy $98 PT reiterated 9/15 — best risk-adjusted entry today.
2	PATK	BUY NOW	7.5	Deeply oversold (RSI 25.29, pos 0), +45% 1d mid forecast, clean fundamentals (fwdPe 13.32, peg 0.89), no bad news.
3	NCLH	BUY PULLBACK	7.2	All 4 timeframes aligned bullish, RSI 25 washed out, but debtEq 6.21 and Wells Fargo cruise-sector cut demand a lower entry.
4	VFC	BUY PULLBACK	6.8	All 3 TFs bullish +8–54%, oversold, but Baird downgrade to Neutral with $15 PT caps the near-term upside.
5	SHAK	BUY PULLBACK	6.5	All 4 TFs bullish +13–56% mid/long, pos_in_range 1–13%, but fwdPe 41.88 and peg 4.07 stretched — wait for $54–56.
6	AMTM	BUY PULLBACK	6.2	4h forecast +45%, fwdPe 7.7 and peg 0.77 attractive, but StockStory sell tag and new 12-month low signal ongoing distribution.
7	TNYA	BUY PULLBACK	5.8	FDA RMAT designation for TN-401 on 9/14 is a real catalyst; short/mid forecast +10–72%, but 1wk forecast -25/-67 is a red flag.
8	IHRT	WAIT	5.2	Expected +36% return with bullish MC prob, but debtEq null/negative profitMargin and recom 4.0 (Sell) undercut conviction.
9	SHMD	WAIT	5.0	+60% expected return but micro-cap $213M, shortFloat 38.3%, no analyst coverage — pure speculation.
10	PACB	WAIT	4.8	+27% expected, but ROE -929% and shortFloat 17.4% make this a squeeze trade not an investment.
11	CLNE	WAIT	4.6	+35% forecast with recom 1.57 and +152% target upside, but operMargin -7.3% and no near-term catalyst on tape.
12	JBLU	WAIT	4.4	+30% forecast and RSI 30.5 oversold, but debtEq 5.91 and recom 3.76 (Hold/Sell) — broken business model.
13	GELS	WAIT	4.2	+26% forecast but $6.6M market cap and operMargin -4107% — essentially unlisted junk risk.
14	ETC-USD	WAIT	4.2	+70.8% forecast crypto play with bullish prob, but no MC data and volatility risk uncontrolled.
15	TIA-USD	WAIT	4.0	+62.8% forecast, bullish prob, small-cap crypto — high beta bet on model alone.
16	FARM-USD	WAIT	3.8	+57% forecast on illiquid alt-coin — treat as lottery ticket at most.
17	NXXT	AVOID	3.5	Already ripped +412% recent bar; $1.27M market cap makes this a pump-and-dump risk despite bullish prob.
18	INTZ	AVOID	3.4	1wk forecast -100% across all horizons is a broken data point — model is confused.
19	XTZ-USD	WAIT	3.4	+51% forecast alt-coin, no fundamentals, allocate only if diversifying crypto sleeve.
20	TPC	AVOID	3.2	bullish_prob 0 and 1wk fc -68% overwhelm decent fundamentals — model wants out.
21	GGB	AVOID	2.8	At 100% of range with 4h/1d/1wk forecasts all -17% to -39% — classic top.
22	TRMD	AVOID	2.6	Pos_in_range 100% on 1d/1wk, all forecasts negative, and secondary offering pricing 9/15 signals overhead supply.
23	NMM	AVOID	2.5	Pos_in_range 100% across 1d/1wk after +33.9% run, forecasts -32% to -58% — sell-the-news setup.
24	COHU	AVOID	2.2	Forecasts -42% to -59% mid/long with negative profitMargin -7.4% — model rejects the +115% YTD move.
25	SENS	AVOID	2.0	Forecast -31%, operMargin -223%, ROE -118% — no support for the bounce.
26	FATE	AVOID	1.8	Forecast -34% after +145% YTD run, profitMargin -1941% — model calling the top.
27	VOD	AVOID	1.6	RSI 74.3 overbought, forecast -28%, targetUpside NEGATIVE -6.6% — everything says sell.
28	MTA	AVOID	1.4	Forecast -38%, PS 59.18 stretched, profitMargin -2.8%, targetUpside only 1.4%.
29	INTC	AVOID	1.2	Forecast -45% after +292% one-year run; fwdPe 46.5 while profitMargin -19.8% — extreme mean-reversion setup.
30	MU	AVOID	0.8	Forecast -62% to -82% mid/long after +488% one-year run — model screams sell into Sept 30 earnings.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord